Blueprint Medicines Corporation

NasdaqGS:BPMC Stock Report

Market Cap: US$7.3b

Blueprint Medicines Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:BPMC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Oct 24SellUS$324,500Fouad NamouniIndividual3,633US$89.32
05 Jun 24SellUS$420,520Percy CarterIndividual4,000US$105.13
03 Jun 24SellUS$207,645Becker HewesIndividual1,951US$106.43
03 Jun 24SellUS$259,263Percy CarterIndividual2,436US$106.43
13 Mar 24SellUS$567,086Philina LeeIndividual6,276US$90.55
07 Mar 24SellUS$132,589Ariel HurleyIndividual1,462US$90.69
07 Mar 24SellUS$228,629Christopher MurrayIndividual2,521US$90.69
07 Mar 24SellUS$266,084Philina LeeIndividual2,934US$90.69
07 Mar 24SellUS$280,867Becker HewesIndividual3,097US$90.69
07 Mar 24SellUS$207,317Percy CarterIndividual2,286US$90.69
07 Mar 24SellUS$471,044Tracey McCainIndividual5,194US$90.69
07 Mar 24SellUS$396,950Fouad NamouniIndividual4,377US$90.69
07 Mar 24SellUS$550,488Christina RossiIndividual6,070US$90.69
07 Mar 24SellUS$453,722Michael LandsittelIndividual5,003US$90.69
07 Mar 24SellUS$1,130,360Kathryn HavilandIndividual12,464US$90.69
07 Mar 24SellUS$461,884Debra Durso-BumpusIndividual5,093US$90.69
07 Mar 24SellUS$1,000,583Jeffrey AlbersIndividual11,033US$90.69

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BPMC?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders655,9220.982%
Institutions66,111,98599%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 76.27% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.2%
BlackRock, Inc.
7,119,049US$818.0m7.1%0.01%
10.5%
The Vanguard Group, Inc.
6,683,434US$768.0m2.22%0.01%
9.66%
T. Rowe Price Group, Inc.
6,135,959US$705.1m-7.94%0.06%
7.11%
FMR LLC
4,516,187US$519.0m-6.56%0.03%
6.24%
Wellington Management Group LLP
3,964,610US$455.6m22.5%0.07%
4.35%
State Street Global Advisors, Inc.
2,765,702US$317.8m16.2%0.01%
2.65%
William Blair Investment Management, LLC
1,681,311US$193.2m5.08%0.22%
2.33%
Geode Capital Management, LLC
1,480,187US$170.1m1.42%0.01%
1.99%
Macquarie Investment Management Business Trust
1,263,661US$145.2m-3.69%0.16%
1.92%
AllianceBernstein L.P.
1,217,705US$139.9m6.91%0.04%
1.85%
Lord, Abbett & Co. LLC
1,178,190US$135.4m-1%0.38%
1.84%
Pictet Asset Management Limited
1,166,507US$134.0m3.48%0.11%
1.76%
JP Morgan Asset Management
1,115,952US$128.2m-1.85%0.01%
1.38%
Polar Capital Holdings Plc
877,005US$100.8m0.23%0.34%
1.28%
American Century Investment Management Inc
815,071US$93.7m1.54%0.04%
1.27%
Invesco Ltd.
808,691US$92.9m1.07%0.02%
1.21%
Rock Springs Capital Management LP
768,776US$88.3m-68.8%2.87%
1.06%
Hood River Capital Management LLC
672,436US$77.3m33.7%1.12%
1.05%
Emerald Advisers, LLC
664,406US$76.3m7.24%1.52%
0.97%
Millennium Management LLC
618,787US$71.1m-1.41%0.06%
0.95%
Alkeon Capital Management, LLC
600,643US$69.0m-19.1%0.43%
0.94%
Charles Schwab Investment Management, Inc.
597,232US$68.6m0%0.01%
0.93%
Brown Advisory Incorporated
593,502US$68.2m-3.93%0.08%
0.93%
Norges Bank Investment Management
592,126US$68.0m0%0.01%
0.87%
Northern Trust Global Investments
555,818US$63.9m2.2%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/26 02:52
End of Day Share Price 2025/01/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Blueprint Medicines Corporation is covered by 32 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Colleen KusyBaird
Ishan MajumdarBaptista Research
Peter LawsonBarclays